gical outcomes do not appear to have improved over 20 years [3] . The high mortality (around 30% for surgical NEC) [3] and long-term morbidity [4, 5] of survivors mandates urgent research into the pathogenesis, diagnosis, prevention, and treatment of this devastating disease. In this review article, it is not our aim to comprehensively describe all new advances in NEC, but instead to describe some areas of progress, focusing wherever possible on clinical studies.
Introduction
Although necrotizing enterocolitis (NEC) is one of the most common life-threatening surgical diseases affecting neonates, we still do not completely understand the pathogenesis or how to prevent or treat the disease [1] . Probiotics have not eradicated the disease [2] and the sur-English neonatal units over 2 years; this included 118,073 infants, of whom 531 (0.4%) developed severe NEC with a mortality of 48% [10] . Interestingly, given the wellknown protective effect of breast milk, in these infants the absolute risk reduction from human milk compared with bovine products was modest. Routinely acquired examination and radiological data from this study have also been used to generate a gestational age-specific case definition, with a sensitivity of 66% and a specificity of 94%, which the authors suggest should be widely adopted [11] . The surgical study, from the British Association of Paediatric Surgeons Congenital Anomalies Surveillance System, collected data from 28 neonatal surgical centres over 1 year and showed that 236 infants required surgery for NEC in the UK in this time period, and highlighted the variation in surgical practices [97] . In both epidemiological studies, infants were identified who died without having surgery. In addition, there are those infants who have a laparotomy in which the whole intestine is necrotic, prompting a decision to withdraw active care. This then leads to the question of whether paediatric surgeons should be intervening earlier, and if so, what should be the indications for surgery? A large multi-institutional study from the USA has attempted to allocate NEC infants into low, intermediate and high risk on the basis of routinely acquired clinical data, including radiological and laboratory findings. Their machine-learning model performs well, and the authors suggest that dynamic risk stratification will assist in determining the need for additional diagnostic testing and guide potential therapies [12] .
Improved Diagnostic Methods
The diagnosis of NEC currently relies on a combination of clinical symptoms and signs, and radiological features encapsulated in the Bell's stages of disease which, although frequently criticized, are still widely used to describe populations of infants with NEC. For many years, researchers have sought plasma, urine or stool biomarkers that would be diagnostic for NEC [13] . One of these biomarkers is intestinal fatty acid binding protein (I-FABP), which is released into the circulation from damaged enterocytes and is excreted in urine. It has been shown in many studies that I-FABP is increased around the time of development of NEC [14] . However, I-FABP concentrations in healthy preterm infants are somewhat variable and the half-life of I-FABP in plasma is short, so that use of the I-FABP concentration in plasma or urine to diagnose early NEC is limited. Similarly, although I-FABP can usefully distinguish those infants who have more extensive disease and thus require more extensive resection [15] , the short half-life means that unless there is ongoing enterocyte damage, some infants with very extensive disease can have paradoxically low I-FABP levels (as all the enterocytes have been lost).
Recently, biomarker discovery studies of the urinary proteome [16] and peptidome [17] have identified proteins and peptides associated with poor outcome (i.e., disease progression). Importantly, the biomarkers alone were not able to completely distinguish progressors from non-progressors, but were able to when clinical factors were incorporated into the prediction model. This raises the question of the clinical utility of these markers -neither an ELISA (for I-FABP) nor mass-spectrometry are currently anywhere near point-of-care testing, so whether they can be usefully incorporated into medical and surgical decision making, particularly when clinical information also has to be taken into account, is uncertain. Circulating cytokines are markers of the systemic immune status, and pro-inflammatory cytokines have long been known to be elevated in NEC. There has been limited information, however, on whether cytokine measurements can be useful in diagnosis or risk assessment in NEC. Using a cytokine array only, IL-10, IL-8, and IL-6 were shown to be significantly higher in surgical NEC than in matched controls [18] . Others have reported similar findings on IL-6 and IL-8. The same researchers then focussed specifically on IL-8, which is a chemoattractant for neutrophils and macrophages, the intestinal expression of which has been linked with NEC [19] . They showed that IL-8 is a suitable marker for preoperative risk assessment, that IL-8 levels obtained within 6 h prior to surgery correlate with the actual intraoperative disease extent [20] , and that high levels correlate with 60-day mortality [21] . Interestingly, although IL-8 is in theory non-specific, whereas I-FABP, as discussed above, is specific for the gut, IL-8 may in fact be a better marker than I-FABP [22] . IL-8 is a routine test in some hospitals so, unlike many laboratory-based biomarkers, it might prove to be clinically useful, although precise cutoffs and criteria for intervention must be developed.
Another type of biomarker that has also seen recent interest is the use of analysis of volatile organic compounds (VOCs) in stool samples as markers of the bacterial metabolism. In a pilot study, there was a difference in the VOC profile in stool samples between control infants and infants with NEC which could be used to predict NEC before clinical symptoms [23] , and a larger study aiming to corroborate these findings is currently underway. Another recent study used an "electronic nose" system, in which VOCs are not quantitatively measured, but differences in intensity across an array of sensors are used to discriminate samples. This study showed that faecal VOC profiles of infants with NEC could be discriminated from controls from 2 to 3 days predating the onset of clinical symptoms [24] . Again, there may be problems in utilizing these interesting biomarkers in a clinically useful way.
Given that most preterm infants will have some form of continual physiological monitoring it would be useful to incorporate these measures into early warning tools to predict NEC. Some neonatal units are now incorporating sophisticated analysis algorithms into their bedside monitoring, and ultimately these may provide just such a prediction tool. Abnormal heart rate characteristics have been suggested as a useful clinical tool to predict sepsis [25] , and have shown initial promise to predict NEC before clinical diagnosis in a prospective trial setting [26] . However, a more recent study in which the same system was used in routine clinical practice suggested that abnormal heart rate characteristics have limited ability to detect sepsis [27] .
Whilst plain radiology remains the primary imaging modality for diagnostic purposes, it is clear that ultrasound (US) has promise for imaging infants with NEC. Pneumatosis intestinalis and portal venous gas are both readily seen during abdominal US and in fact portal venous gas may be detected earlier by US than by plain radiography. However, it is the ability of US to detect infants with more advanced disease and those who may benefit from surgery that has attracted the greatest attention. US permits examination of the intestinal wall in a much more detailed way than is possible with plain radiographs and in particular allows an assessment of the thickness and perfusion of the intestinal wall and peristalsis. Characteristic perfusion patterns have been associated with inflammation, ischaemia, and necrosis [28] . Further information that can be obtained includes the presence of free intraabdominal gas and the presence and nature of any free intra-abdominal fluid that may be indicative of intestinal perforation. The real challenge is to determine whether US can be used to accurately identify infants with NEC who would benefit from surgery [28, 29] . Further prospective evaluation is undoubtedly needed.
Near-infrared spectroscopy (NIRS) provides a noninvasive measurement of tissue oxygen saturation, potentially allowing a real-time window into intestinal perfusion which is measured as tissue fractional oxygen saturation after taking into account arterial saturation concomitantly measured by pulse oximetry. Although one might assume that in NEC infants intestinal perfusion would be lower in infants predisposed to NEC, in fact cerebral oxygenation rather than intestinal oxygenation is impaired in the first days of life in infants who go on to develop NEC, whereas intestinal perfusion is impaired immediately preceding clinical NEC [30] . In a further study, although NIRS could not distinguish between definite NEC and the absence of NEC, it could differentiate between complicated and uncomplicated NEC [31] . Encouragingly, these differences in NIRS readings also correlated well with I-FABP levels, thus validating the use of NIRS to examine intestinal impairment [32] .
Pathogenesis
The main factors thought to be involved in the pathogenesis of NEC are intestinal immaturity, enteral feeds, the intestinal microbiome, inflammation, and local ischaemia and/or reperfusion injury. We will briefly discuss recent research in each of these areas.
Intestinal Immaturity
The fetal gut develops in an environment where exposure to microbes is limited. Therefore, preterm infants are exposed to a much greater diversity and quantity of bacteria, viruses, and fungi. The preterm infant gut displays an excessive inflammatory response [19] , and toll-like receptor 4 (TLR4) seems to play a key role in this inflammatory response [33] (see below). However, a difference in inflammatory response is not the only aspect of the preterm infant intestine that might be affected. The neonatal gut also seems to be more susceptible to intestinal ischaemia/reperfusion injury than the adult gut [34] , and the activity of carbohydrate digestive enzymes is significantly lower in the preterm intestine than term intestine [35] . Gut motility is also different in preterm and term infants [36] . Another potentially important difference between preterm and term infants is that of maternal separation. Partial separation of mouse pups from the mother is enough to induce changes in colonic histology and permeability [37] , although the relevance of these observations to NEC is unknown.
Enteral Feeding
Although it has long been known that, firstly, NEC predominantly occurs in preterm infants who have been enterally fed and, secondly, human breast milk is protec-tive for NEC, we do not completely understand how the type of feed interacts with other risk factors. Interestingly, the protective effect of breast milk appears to be dose related [38] , although, as discussed in the epidemiology section above, the absolute risk reduction may be modest [10] . A huge array of protective factors present in breast milk has been suggested and some of these have been proposed as potential preventative measures or treatments (see below). One mechanism by which feed components could influence intestinal gene expression is epigenetics, defined as "relating to or arising from non-genetic influences on gene expression." As epigenetic changes frequently involve methylation, they are potentially influenced by diet. A current area of research interest is the potential epigenetic effects of breast milk and other enteral feeds [39] . Marked epigenetic changes have been observed in the intestine of preterm infants [40] , and in a pig model enteral feeding has been linked with epigenetic changes causing the upregulation of pro-inflammatory genes [41] . In addition, the type of enteral feed can also interact with the other risk factors described below, such as the gut microbiome [42] and intestinal blood flow [43] .
Intestinal Microbiome
While the precise role of bacterial agents in the development of NEC is unclear, several factors implicate their involvement. Occasionally NEC occurs in clusters in which identical organisms are responsible [44] . However, different organisms are grown from separate outbreaks so it cannot be claimed that a single organism is involved in the development of NEC. Bacterial involvement in the pathogenesis of NEC is also implicated by association; endotoxaemia [45, 46] and positive blood cultures are common in infants with NEC and the gastrointestinal pneumatosis found in NEC contains 30% hydrogen [47] , a gas produced solely by bacterial metabolism. As long ago as 1975, it was hypothesized that a dysbiosis (imbalance between protective microflora and harmful microflora) was involved in the pathogenesis of NEC [48] . Recent interest in the intestinal microbiome and availability of highthroughput pyrosequencing techniques has led to several relevant research studies in NEC. However, such data are very complex and their analysis in a very heterogeneous disease like NEC is extremely challenging, especially where both the nosocomial microbiota and their measurement methods vary among neonatal units [49] . Nevertheless, studies suggest a loss in microbial diversity to occur immediately before NEC onset [50, 51] . These preliminary findings have been recently corroborated by a large multicentre study [52] .
Inflammation
Histologically, there is a massive intestinal inflammatory response in NEC. It has even been suggested that there may be antenatal precedents to this exaggerated inflammatory response, such as chorioamnionitis. A recent systematic review and meta-analysis of available studies concluded that chorioamnionitis increases the risk of NEC [53] . Differences in the immune response to mucosal damage and the microbiota may also be responsible for the exaggerated inflammatory response in NEC [54] . Recent studies have highlighted such differences, such as those showing that intraepithelial T cell receptor γδ lymphocytes are decreased in surgical NEC specimens compared with appropriate controls [55] , as are lamina propria T regulatory cells [56] . A key player in intestinal inflammation and the response to pathogens is TLR4, and recent work has shown that TLR4 signalling is important in the development of NEC [33, [57] [58] [59] . Intriguingly, TLR4 signalling also links to other factors involved in the pathogenesis of NEC, such as the microcirculation [59] (see below).
Ischaemic Injury
From early descriptions, ischaemia/reperfusion injury due to relative splanchnic hypoperfusion was thought to play a part in the pathogenesis of NEC. A primary role for intestinal ischaemic damage long fell out of favour, but recently some evidence from both animal models and clinical studies has resurrected the potential role of intestinal ischaemia, although probably not as the sole initiating factor. Experimental studies have suggested that in NEC there is impairment in intestinal microcirculation [60] [61] [62] which can be improved by direct peritoneal resuscitation [63] [64] [65] [66] . A potential role for splanchnic hypoperfusion in NEC has been suggested from a variety of clinical studies. Firstly, there is a decline in mesenteric oxygenation when preterm infants are fed during red blood cell transfusion [67] . Secondly, there is increasing recognition that an important subset of infants with NEC have congenital cardiac disease that may predispose to splanchnic hypoperfusion [68] . Thirdly, several clinical studies have suggested that arginine and/or citrulline, amino acids, which are important in the production of nitric oxide and regulation of intestinal blood flow, are decreased in NEC and that the supplementation of infants with arginine may prevent NEC [69] [70] [71] [72] [73] . Finally, a recent histological study of resection tissue from infants with NEC showed that hypoxia markers, hypoxia-inducible factor 1α (HIF-1α) and glucose transporter 1 (GLUT1), were elevated in NEC but not in spontaneous intestinal perforation or where only a short segment of the bowel was affected [74] .
Prevention

Dietary/Pharmacological Approaches
There are several suggested dietary and/or pharmacological approaches to the prevention of NEC. Many of these agents are found in human breast milk, for example lactoferrin is a glycoprotein that forms part of the innate immune response. A small randomised study in very low birth weight infants found that episodes of sepsis were reduced in infants given oral human lactoferrin, but none in either the treatment or placebo group developed NEC [75] . A randomised controlled trial of bovine lactoferrin showed a reduced incidence of NEC compared to controls, and a reduced risk of death or progression to stage 3 NEC [76] . Oligosaccharides are complex carbohydrates that are components present at much higher concentrations in human breast milk than formula milk. They prevent NEC in a rodent model [77] , have shown promise in preventing NEC in a limited human trial [78] , and seem to have generated a recent flurry of activity amongst patent lawyers. Another series of compounds that have potential use in preventing NEC is a new class of TLR4 inhibitors which, by preventing TLR4 activation, may inhibit the inflammatory cascade in NEC [79, 80] . Of course, probiotics have polarized the neonatal community regarding their ability (or not) to prevent NEC [81] . An extensive discussion is beyond the scope of this review and unfortunately we seem no closer to a definitive answer despite large-scale trials, such as ProPrems [82] and PIPS [83] . Hopefully, mechanistic studies [84] [85] [86] [87] together with a more detailed understanding of the microbiome and its influence on the development of NEC (referred to above) will help us find a way out of this impasse.
Therapy
Recent evidence from 3 different research groups has suggested that stem cells are able to influence the course of the disease in experimental NEC [88] : amniotic fluid stem (AFS) cells [89] , mesenchymal stem cells [90, 91] , and enteric neural stem system cells [92] . In addition to the beneficial effects of AFS cells and the conditioned medium from AFS cells, other recent evidence highlights the potential role of factors in amniotic fluid in the prevention and/or treatment of NEC. Pig and human amniotic fluid, centrifuged so therefore presumed to be largely cell free, stimulate the proliferation and migration of rat intestinal epithelial cells in vitro [93] . In a well-established, clinically relevant model of spontaneous NEC in preterm piglets, postnatal minimal enteral feeding with porcine amniotic fluid decreased inflammation together with the incidence and severity of NEC [94] , but had no effect when given later with full enteral feeding, although the beneficial effect during minimal enteral feeding was not consistently observed [93, 94] . Another group has shown that enteral delivery of amniotic fluid decreases the severity of NEC in a mouse model [95] . This effect is mediated via epidermal growth factor (EGF) present in amniotic fluid, and its receptor, EGFR. In additional experiments, both in vitro and in vivo amniotic fluid modulated the ability of lipopolysaccharide to trigger TLR4-dependent inflammatory signalling, and these effects were mediated via EGF/EGFR [95] . It has also been suggested that these protective effects of amniotic fluid are mediated via hepatocyte growth factor [96] .
Conclusions
Despite understanding the cardinal features involved in the pathogenesis of NEC, and decades of research, we still do not fully understand this devastating disease, how to prevent it or treat it. Nevertheless, the broad range and depth of research on the topic does lead to a degree of optimism that clinicians and scientists will hopefully be able to deliver novel preventative, diagnostic, and therapeutic strategies that will translate into improved outcomes.
